Labcorp Holdings Working Capital Growth & History (LH)
Labcorp Holdings's working capital was $1.20B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.20B | −$279.3M | −18.92% |
| 2024 | 2024-12-31 | $1.48B | $936.1M | +173.29% |
| 2023 | 2023-12-31 | $540.2M | −$1.01B | −65.07% |
| 2022 | 2022-12-31 | $1.55B | −$1.00B | −39.30% |
| 2021 | 2021-12-31 | $2.55B | $500.7M | +24.46% |
| 2020 | 2020-12-31 | $2.05B | $1.72B | +529.04% |
| 2019 | 2019-12-31 | $325.4M | −$631.1M | −65.98% |
| 2018 | 2018-12-31 | $956.5M | $408.4M | +74.51% |
| 2017 | 2017-12-31 | $548.1M | −$103.0M | −15.82% |
| 2016 | 2016-12-31 | $651.1M | −$269.6M | −29.28% |
| 2015 | 2015-12-31 | $920.7M | $204.3M | +28.52% |
| 2014 | 2014-12-31 | $716.4M | $20.0M | +2.87% |
| 2013 | 2013-12-31 | $696.4M | $333.1M | +91.69% |
| 2012 | 2012-12-31 | $363.3M | $35.9M | +10.97% |
| 2011 | 2011-12-31 | $327.4M | $304.1M | +1305.15% |
| 2010 | 2010-12-31 | $23.3M | $106.1M | — |
| 2009 | 2009-12-31 | −$82.8M | −$568.7M | — |
| 2008 | 2008-12-31 | $485.9M | — | — |
Labcorp Holdings quarterly working capital
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.69B | $319.9M | +23.34% |
| Q1 2026 | 2026-03-31 | $1.92B | $192.7M | +11.17% |
| Q4 2025 | 2025-12-31 | $1.20B | −$279.3M | −18.92% |
| Q3 2025 | 2025-09-30 | $1.45B | −$48.3M | −3.22% |
| Q2 2025 | 2025-06-30 | $1.37B | $1.86B | — |
| Q1 2025 | 2025-03-31 | $1.73B | $2.21B | — |
| Q4 2024 | 2024-12-31 | $1.48B | $936.1M | +173.29% |
| Q3 2024 | 2024-09-30 | $1.50B | $444.5M | +42.20% |
| Q2 2024 | 2024-06-30 | −$493.4M | −$3.43B | — |
| Q1 2024 | 2024-03-31 | −$485.0M | −$2.29B | — |
| Q4 2023 | 2023-12-31 | $540.2M | −$1.01B | −65.07% |
| Q3 2023 | 2023-09-30 | $1.05B | −$796.1M | −43.04% |
| Q2 2023 | 2023-06-30 | $2.94B | $549.7M | +23.02% |
| Q1 2023 | 2023-03-31 | $1.81B | −$778.6M | −30.09% |
| Q4 2022 | 2022-12-31 | $1.55B | −$1.00B | −39.30% |
| Q3 2022 | 2022-09-30 | $1.85B | −$1.28B | −40.95% |
| Q2 2022 | 2022-06-30 | $2.39B | −$638.5M | −21.10% |
| Q1 2022 | 2022-03-31 | $2.59B | $318.6M | +14.04% |
| Q4 2021 | 2021-12-31 | $2.55B | $500.7M | +24.46% |
| Q3 2021 | 2021-09-30 | $3.13B | $2.06B | +191.17% |
| Q2 2021 | 2021-06-30 | $3.03B | $2.65B | +698.94% |
| Q1 2021 | 2021-03-31 | $2.27B | $1.84B | +423.99% |
| Q4 2020 | 2020-12-31 | $2.05B | $1.72B | +529.04% |
| Q3 2020 | 2020-09-30 | $1.08B | $642.8M | +148.49% |
| Q2 2020 | 2020-06-30 | $378.8M | $26.0M | +7.37% |
| Q1 2020 | 2020-03-31 | $433.1M | $74.7M | +20.84% |
| Q4 2019 | 2019-12-31 | $325.4M | −$631.1M | −65.98% |
| Q3 2019 | 2019-09-30 | $432.9M | −$735.2M | −62.94% |
| Q2 2019 | 2019-06-30 | $352.8M | −$546.9M | −60.79% |
| Q1 2019 | 2019-03-31 | $358.4M | −$434.2M | −54.78% |
| Q4 2018 | 2018-12-31 | $956.5M | $408.4M | +74.51% |
| Q3 2018 | 2018-09-30 | $1.17B | −$195.3M | −14.32% |
| Q2 2018 | 2018-06-30 | $899.7M | $189.5M | +26.68% |
| Q1 2018 | 2018-03-31 | $792.6M | $59.8M | +8.16% |
| Q4 2017 | 2017-12-31 | $548.1M | −$103.0M | −15.82% |
| Q3 2017 | 2017-09-30 | $1.36B | $620.7M | +83.57% |
| Q2 2017 | 2017-06-30 | $710.2M | −$662.3M | −48.26% |
| Q1 2017 | 2017-03-31 | $732.8M | −$369.4M | −33.51% |
| Q4 2016 | 2016-12-31 | $651.1M | −$269.6M | −29.28% |
| Q3 2016 | 2016-09-30 | $742.7M | −$120.0M | −13.91% |
| Q2 2016 | 2016-06-30 | $1.37B | $609.6M | +79.91% |
| Q1 2016 | 2016-03-31 | $1.10B | $185.9M | +20.29% |
| Q4 2015 | 2015-12-31 | $920.7M | $204.3M | +28.52% |
| Q3 2015 | 2015-09-30 | $862.7M | −$76.1M | −8.11% |
| Q2 2015 | 2015-06-30 | $762.9M | −$62.2M | −7.54% |
| Q1 2015 | 2015-03-31 | $916.3M | $249.0M | +37.31% |
| Q4 2014 | 2014-12-31 | $716.4M | $20.0M | +2.87% |
| Q3 2014 | 2014-09-30 | $938.8M | $406.5M | +76.37% |
| Q2 2014 | 2014-06-30 | $825.1M | $332.2M | +67.40% |
| Q1 2014 | 2014-03-31 | $667.3M | $217.8M | +48.45% |
| Q4 2013 | 2013-12-31 | $696.4M | $333.1M | +91.69% |
| Q3 2013 | 2013-09-30 | $532.3M | $195.9M | +58.23% |
| Q2 2013 | 2013-06-30 | $492.9M | $148.1M | +42.95% |
| Q1 2013 | 2013-03-31 | $449.5M | $136.8M | +43.75% |
| Q4 2012 | 2012-12-31 | $363.3M | $35.9M | +10.97% |
| Q3 2012 | 2012-09-30 | $336.4M | $246.0M | +272.12% |
| Q2 2012 | 2012-06-30 | $344.8M | $286.9M | +495.51% |
| Q1 2012 | 2012-03-31 | $312.7M | $364.8M | — |
| Q4 2011 | 2011-12-31 | $327.4M | $304.1M | +1305.15% |
| Q3 2011 | 2011-09-30 | $90.4M | $93.0M | — |
| Q2 2011 | 2011-06-30 | $57.9M | $37.7M | +186.63% |
| Q1 2011 | 2011-03-31 | −$52.1M | −$146.7M | — |
| Q4 2010 | 2010-12-31 | $23.3M | $106.1M | — |
| Q3 2010 | 2010-09-30 | −$2.6M | −$377.5M | — |
| Q2 2010 | 2010-06-30 | $20.2M | −$481.3M | −95.97% |
| Q1 2010 | 2010-03-31 | $94.6M | — | — |
| Q4 2009 | 2009-12-31 | −$82.8M | −$568.7M | — |
| Q3 2009 | 2009-09-30 | $374.9M | — | — |
| Q2 2009 | 2009-06-30 | $501.5M | — | — |
| Q4 2008 | 2008-12-31 | $485.9M | — | — |
Labcorp Holdings working capital trends
Over the last five fiscal years, Labcorp Holdings's working capital decreased from $2.05B to $1.20B, a change of −$849.9M. The latest reported quarter, Q2 2026, shows $1.69B.
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...